Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis.
Primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC) are chronic progressive cholestatic diseases that frequently lead to biliary cirrhosis. The exact pathogenesis of these diseases remains elusive but is likely immunologically based. Complications range from fatigue and pruritus to end-stage liver disease. The risk of developing hepatocellular carcinoma is low for patients with PBC, whereas cholangiocarcinoma is common in PSC and carries an ominous prognosis. Although ursodeoxycholic acid is effective in slowing the progression of PBC, no effective medical therapy exists for PSC. Liver transplantation is the only option for patients with end-stage liver disease and yields excellent long-term survival in both groups.
Franco
J
J
Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA.
Saeian
K
K
D001650:Bile Duct Neoplasms / Q000175:diagnosis / Q000209:etiology; D018281:Cholangiocarcinoma / Q000175:diagnosis / Q000209:etiology; D015209:Cholangitis, Sclerosing / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D016031:Liver Transplantation; D012307:Risk Factors; D014580:Ursodeoxycholic Acid
D014580:Ursodeoxycholic Acid